Phase I trial of oral etoposide in combination with celecoxib in patients with advanced malignancies.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib; Etoposide
- Indications Cancer; Solid tumours
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 22 Nov 2012 Biomarkers information updated
- 19 Oct 2011 Planned end date (Oct 2012) added as reported by ClinicalTrials.gov.
- 17 Nov 2007 New trial record.